{{Drugbox
| IUPAC_name =  
| image = Sodium apolate.svg
| width = 150

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 25053-27-4
| ATC_prefix = C05
| ATC_suffix = BA02
| PubChem = 3270262
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9461405D9F
| KEGG = D04825
| ChemSpiderID = none
<!--Chemical data-->
| chemical_formula = (C<sub>2</sub>H<sub>3</sub>NaO<sub>3</sub>S)<sub>n</sub>, with n~25

| molecular_weight =  
}}
'''Sodium apolate''' ([[International Nonproprietary Name|INN]]) or '''lyapolate sodium''' ([[United States Adopted Name|USAN]]) is a [[vasoprotective]].

{{Vasoprotectives}}


[[Category:Organic sodium salts]]
[[Category:Vinyl polymers]]
[[Category:Sulfonates]]


{{cardiovascular-drug-stub}}